NPY Y5 receptor subtype. Pharmacological characterization with antisense oligodeoxynucleotide screening strategy.
Schaffhauser
A O
AO
Lonza Ltd., Basel, Switzerland.
Stricker-Krongrad
A
A
Hofbauer
K G
KG
D000818:Animals; D002478:Cells, Cultured; D004435:Eating / Q000502:physiology*; D019004:Galanin / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D051379:Mice; D009478:Neuropeptide Y / Q000378:metabolism*; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger / Q000378:metabolism; D011869:Radioligand Assay; D051381:Rats; D017476:Receptors, Neuropeptide Y / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013873:Thionucleotides
D009478:Neuropeptide Y; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D017476:Receptors, Neuropeptide Y; D013873:Thionucleotides; C100568:neuropeptide Y5 receptor; D019004:Galanin